Research indicates that nasal spray bioavailability for peptides like BPC-157 ranges from 40-60%, depending on formulation and individual factors
many patients experience stable symptoms with periods of exacerbation, and a small subset may develop significant issues
Modulating immune function, reducing the risk of autoimmune dysfunction and chronic inflammation
Neurocognitive Disorders Abundant data shows that neurocognitive disorders such as dementia or mild cognitive impairment are commonly accompanied by abnormalities of sleep and circadian rhythms
Although CB1 monotherapy weight loss data was not equivalent to GLP-1, it did show a 5.8% weight loss placebo reduction at 16 weeks
Maureen also offers services pertaining to group health and welfare benefits, executive benefits, retirement planning, and estate and financial planning strategies